219 related articles for article (PubMed ID: 26543233)
1. A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
Xie K; Ma H; Liang C; Wang C; Qin N; Shen W; Gu Y; Yan C; Zhang K; Dai N; Zhu M; Wu S; Wang H; Dai J; Jin G; Shen H; Hu Z
Oncotarget; 2015 Dec; 6(40):42781-92. PubMed ID: 26543233
[TBL] [Abstract][Full Text] [Related]
2. MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.
Ji J; Xu M; Tu J; Zhao Z; Gao J; Chen M; Song J; Zhu H; Cheng X; Hui J; Lan X; Yang X
Oncotarget; 2016 Sep; 7(37):60303-60309. PubMed ID: 27531892
[TBL] [Abstract][Full Text] [Related]
3. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
7. The miR-146a SNP Rs2910164 and miR-155 SNP rs767649 Are Risk Factors for Non-Small Cell Lung Cancer in the Iranian Population.
Dezfuli NK; Adcock IM; Alipoor SD; Seyfi S; Salimi B; Mafi Golchin M; Dalil Roofchayee N; Varhram M; Mortaz E
Can Respir J; 2020; 2020():8179415. PubMed ID: 33294082
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.
Ding X; Yang Y; Sun Y; Xu W; Su B; Zhou X
Clin Transl Oncol; 2017 May; 19(5):546-552. PubMed ID: 27743168
[TBL] [Abstract][Full Text] [Related]
10. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
11. The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4.
Huang W; Li H; Luo R
Diagn Pathol; 2015 Jul; 10():127. PubMed ID: 26209100
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
Liu L; Qu W; Zhong Z
Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
[TBL] [Abstract][Full Text] [Related]
14. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
15. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
17. The rs767649 polymorphism in the promoter of miR-155 contributes to the decreased risk for cervical cancer in a Chinese population.
Wang S; Cao X; Ding B; Chen J; Cui M; Xu Y; Lu X; Zhang Z; He A; Jin H
Gene; 2016 Dec; 595(1):109-114. PubMed ID: 27717891
[TBL] [Abstract][Full Text] [Related]
18. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
Xie K; Wang C; Qin N; Yang J; Zhu M; Dai J; Jin G; Shen H; Ma H; Hu Z
Oncotarget; 2016 Jul; 7(30):47966-47974. PubMed ID: 27374108
[TBL] [Abstract][Full Text] [Related]
20. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
